|[March 19, 2013]
Rigrodsky & Long, P.A. Announces Investigation Of Palomar Medical Technologies, Inc. Buyout
WILMINGTON, Del. --(Business Wire)--
Rigrodsky & Long, P.A.:
Do you own shares of Palomar Medical Technologies, Inc. (NASDAQ GS: PMTI)
Did you purchase any of your shares prior to March 18, 2013
Do you think the proposed buyout price is too low
Do you want to discuss your rights
& Long, P.A. announces that it is investigating potential legal
claims against the board of directors of Palomar Medical Technologies,
Inc. ("Palomar" or the "Company") (NASDAQ GS: PMTI)
regarding possible breaches of fiduciary duties and other violations of
law related to the Company's entry into an agreement to be acquired by
Cynosure, Inc. ("Cynosure") (NASDAQ GS: CYNO)
in a transaction valued at approximately $294 million.
Click here to learn more: http://www.rigrodskylong.com/investigations/palomar-medical-technologies-inc-pmti.
Under the terms of the proposal, public shareholders of Palomar will
receive $13.65 per share of Palomar common stock: $6.825 per share in
cash and $6.825 per share in Cynosure common stock.
The investigation concerns whether Palomar's board of directors failed
to adequately shop the Company and obtain the best possible value for
Palomar's shareholders before entering into an agreement with Cynosure.
According to Yahoo! Finance, at least one analyst has set a price target
for Palomar stock at $14.50 per share.
If you own the common stock of Palomar and purchased your shares before
March 18, 2013, if you have information or would like to learn more
about these claims, or if you wish to discuss these matters or have any
questions concerning this announcement or your rights or interests with
respect to these matters, please contact Seth Rigrodsky or Brian Long at
Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington,
Delaware 19803, by telephone at (302) 295-5310, or Peter Allocco at
Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City,
New York 11530, by telephone at (888) 969-4242; by e-mail to email@example.com,
or at: http://www.rigrodskylong.com/investigations/palomar-medical-technologies-inc-pmti.
& Long, P.A., with offices in Wilmington, Delaware and Garden
City, New York, regularly prosecutes securities
class, derivative and direct actions, shareholder rights litigation and
corporate governance litigation, on behalf of shareholders in states
and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.
[ Back To Technology News's Homepage ]